Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnab K Chatterjee

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
ACS Infectious Diseases|May 14, 2024
Bicyclic Pyrrolidine Inhibitors of <i>Toxoplasma gondii</i> Phenylalanine t-RNA Synthetase with Antiparasitic Potency In Vitro and Brain ExposureChloe C Ence, Taher Uddin, Julien Borrel, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2023
Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agentsBaiyuan Yang, Paridhi Sukheja, Bo Qin, et al.
Antiviral Research|June 29, 2021
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agentsThuc Nguyen Dan Do, Kim Donckers, Laura Vangeel, et al.
Science (New York, N.Y.)|April 15, 2017
Decarboxylative borylationChao Li, Jie Wang, Lisa M Barton, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
Pharmacological YAP activation promotes regenerative repair of cutaneous woundsEdyta M Grzelak, N G R Dayan Elshan, Sida Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Cell-based screen for discovering lipopolysaccharide biogenesis inhibitorsGe Zhang, Vadim Baidin, Karanbir S Pahil, et al.
Nature Communications|January 25, 2022
Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetaseJoshua B Radke, Bruno Melillo, Payal Mittal, et al.
Nature|October 17, 2018
A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signallingMichael J Bollong, Gihoon Lee, John S Coukos, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-arylPhillip B Alper, Hong Liu, Arnab K Chatterjee, et al.
Bioconjugate Chemistry|May 7, 2015
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug ConjugateReyna K V Lim, Shan Yu, Bo Cheng, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
ACS Infectious Diseases|May 14, 2024
Bicyclic Pyrrolidine Inhibitors of <i>Toxoplasma gondii</i> Phenylalanine t-RNA Synthetase with Antiparasitic Potency In Vitro and Brain ExposureChloe C Ence, Taher Uddin, Julien Borrel, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2023
Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agentsBaiyuan Yang, Paridhi Sukheja, Bo Qin, et al.
Antiviral Research|June 29, 2021
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agentsThuc Nguyen Dan Do, Kim Donckers, Laura Vangeel, et al.
Science (New York, N.Y.)|April 15, 2017
Decarboxylative borylationChao Li, Jie Wang, Lisa M Barton, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2023
Pharmacological YAP activation promotes regenerative repair of cutaneous woundsEdyta M Grzelak, N G R Dayan Elshan, Sida Shao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2018
Cell-based screen for discovering lipopolysaccharide biogenesis inhibitorsGe Zhang, Vadim Baidin, Karanbir S Pahil, et al.
Nature Communications|January 25, 2022
Bicyclic azetidines target acute and chronic stages of Toxoplasma gondii by inhibiting parasite phenylalanyl t-RNA synthetaseJoshua B Radke, Bruno Melillo, Payal Mittal, et al.
Nature|October 17, 2018
A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signallingMichael J Bollong, Gihoon Lee, John S Coukos, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-arylPhillip B Alper, Hong Liu, Arnab K Chatterjee, et al.
Bioconjugate Chemistry|May 7, 2015
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug ConjugateReyna K V Lim, Shan Yu, Bo Cheng, et al.
Pageof 11